Labshake search
Citations for R&D Systems :
1 - 50 of 2416 citations for Galectin 1 Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2023Quote: ... anti-Galectin-3 (1:50; R&D systems, AF1197), anti-Hsp70 (1:300 ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-Galectin-3 (1:50; R&D systems, AF1197 & 1:100; Biolegend, 125401), anti-Hsp70 (1:300 ...
-
bioRxiv - Microbiology 2022Quote: ... Galectin 8 (R&D systems, AF1305), anti-goat IgG 633 (Invitrogen ...
-
bioRxiv - Cell Biology 2019Quote: ... goat anti-Galectin-9 (AF2045, R&D systems) at 20 μg/ml ...
-
bioRxiv - Neuroscience 2021Quote: ... goat anti-Galectin-3 (R&D Systems, AF1154), goat anti-GPNMB (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... A Galectin-7 ELISA kit (R&D Systems) was used to measure its concentration in the plasma of patients.
-
bioRxiv - Cancer Biology 2021Quote: ... Galectin-9 primary antibody (R&D systems, AF-2045) was added to sections at 1 μg/mL dilution and incubated overnight at 4 °C ...
-
bioRxiv - Cell Biology 2019Quote: ... goat anti-Galectin-9 (AF2045, R&D systems, Minneapolis, Minnesota) at 1:1000 (v/v ...
-
bioRxiv - Cell Biology 2022Quote: ... Mouse Galectin-3 DuoSet (all from R&D Systems,UK).
-
bioRxiv - Immunology 2023Quote: ... cDC2s were stained in PBA buffer with anti-galectin-9 antibody (1:50, AF2045, R&D systems) and anti-CCR7 (1:200 ...
-
bioRxiv - Immunology 2023Quote: ... moDCs were treated with recombinant galectin-9 protein (AF2045, R&D systems) at a final concentration of 1 µg/ml.
-
bioRxiv - Cell Biology 2019Quote: ... coverslips were subsequently incubated with anti-Galectin-9 antibody (AF23045, R&D systems) for 2 h at room temperature ...
-
bioRxiv - Cell Biology 2019Quote: ... goat anti-human Galectin-9 at 20 μg/ml (AF23045, R&D systems); mouse monoclonal Rac1 (240106 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Recombinant human galectin 3 binding protein (R&D Systems, and produced in-house), QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies) ...
-
bioRxiv - Microbiology 2020Quote: ... and then stained with goat anti-human galectin-8 antibody (R&D Systems, AF1305) diluted in PB solution overnight at 4°C ...
-
bioRxiv - Microbiology 2022Quote: ... and then stained with goat anti-human galectin-8 antibody (R&D Systems, AF1305) diluted in PB solution overnight at 4°C ...
-
bioRxiv - Cell Biology 2023Quote: ... The remaining volume was divided into two tubes and incubated on ice with either 1 μg of anti-galectin-9 (AF2545, R&D systems) or goat isotype control (Jackson Immunoresearch ...
-
bioRxiv - Cell Biology 2023Quote: ... single cell suspensions were stained with a goat anti-galectin-9 antibody (AF2045, R&D systems) at 40 μg/ml or isotype control as negative control for 30 min at 4 °C ...
-
bioRxiv - Cell Biology 2023Quote: ... Cell lysates were then incubated with 2 μg of anti-galectin-9 (AF2545, R&D systems) or isotype control under rotation ...
-
bioRxiv - Immunology 2023Quote: ... single cell suspensions were stained with a goat anti-galectin-9 antibody (AF2045, R&D systems) at 8 μg/ml or isotype control as negative control for 30 min at 4 °C ...
-
bioRxiv - Physiology 2020Quote: ... PD-1 blocking antibody (R&D Systems/Techne, #AF1086) was included at the 10 µg/ml ...
-
bioRxiv - Microbiology 2020Quote: ... Recombinant human galectin-4 (GAL4 P56470) and gelsolin (GSN Q3SX14) from bovine plasma were purchased from R&D Systems and Sigma respectively.
-
bioRxiv - Cell Biology 2023Quote: ... The following primary antibodies were used for Western Blotting: goat anti-Galectin-9 (AF2045, R&D systems, Minneapolis, Minnesota) at 1:1000 (v/v) ...
-
bioRxiv - Immunology 2023Quote: ... The following primary antibodies were used for Western Blotting: goat anti-Galectin-9 (AF2045, R&D systems, Minneapolis, Minnesota) at 1:1000 (v/v) ...
-
bioRxiv - Bioengineering 2023Quote: ... and a TGFβ blocking antibody (20 µg mL-1, #MAB1835, R&D Systems). Trastuzumab (#MAB9589 ...
-
bioRxiv - Immunology 2023Quote: ... 30 µg/ml of anti-LOX-1 blocking antibody (polyclonal, R&D Systems) or goat IgG isotype (Biolegend ...
-
bioRxiv - Cell Biology 2022Quote: ... Rabbit anti-ALIX and rabbit anti-CHMP4B antibodies were described previously (Christ et al, 2016). Human Galectin-3 Alexa Fluor 488-conjugated antibody (cat. no. IC1154G) was purchased from R&D Systems. Mouse anti-LAMP1 (cat ...
-
bioRxiv - Cancer Biology 2019Quote: ... Each well was supplemented with PDGFR-α blocking antibody (1:100; R&D Systems), or Imatinib (Seleckchem) ...
-
bioRxiv - Neuroscience 2021Quote: ... and incubated for 1 hour with blocking buffer (Reagent Diluent, R&D Systems, UK). Plates were washed 3 times with wash buffer and 100 ul of samples and standards were added (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: cleaved caspase 3 (Cat. No. MAB835, 1:200 in blocking solution, R&D Systems), dsDNA (Cat No ...
-
bioRxiv - Immunology 2020Quote: ... the plate was washed 3 times and incubated with 80 µL per well of monoclonal mouse IgG2B human sRAGE or galectin-3 antibody (R&D Systems, Minneapolis, Minnesota, United States) at a concentration of 0.2 µg/ml for 30 minutes shaking at room temperature ...
-
bioRxiv - Microbiology 2024Quote: ... and treated with a blocking solution (dPBS +Ca2 +Mg2 with 2% (v/v) FBS) containing an anti-hTIM1(1:50-1:100, AF1750, R&D Systems) antibody ...
-
bioRxiv - Immunology 2019Quote: ... blocking anti-CXCR4 MAB21651 (247506, R&D Systems) or anti-CCR7 MAB3477 (4B12 ...
-
bioRxiv - Pharmacology and Toxicology 2019Quote: ... the samples were incubated with primary anti-TRKB antibody (1:1000 in blocking buffer, #AF1494, R&D Systems) ON at 4°C ...
-
bioRxiv - Cancer Biology 2022Quote: ... as previously described.30 The concentrations of function blocking antibodies used were: 1 μg mL−1 Anti-laminin 5 antibody (R&D systems, #MAB2144), 1 μg mL−1 α3 anti-integrin antibody ...
-
bioRxiv - Immunology 2020Quote: ... and Alexa Fluor 594 labelled anti-human DAP10/HCST (R&D Systems, 1:500 v/v in blocking buffer) to stain for the cytoskeleton and DAP10 clusters respectively ...
-
bioRxiv - Immunology 2024Quote: ... and anti-B220 (Rat anti-mouse; monoclonal: RA3-6B2 clone; dilution 1:100 in blocking solution; R&D systems). Secondary antibody staining was performed for 50min at room temperature ...
-
bioRxiv - Cell Biology 2022Quote: ... αCCR7 blocking antibody (R&D systems, 2-5μg/ml), rat immunoglobulin (Ig ...
-
bioRxiv - Neuroscience 2022Quote: ... Anti-Nrp2 function blocking antibody (AF2215, R&D Systems) was applied at a concentration of 10 µg/mL ...
-
bioRxiv - Immunology 2023Quote: ... Siglec-9 blocking antibody (Clone 191240, R&D Systems) was added at a final concentration of 10 µg/mL ...
-
bioRxiv - Immunology 2023Quote: ... Siglec-9 blocking antibody (Clone 191240, R&D Systems) was added at a final concentration of 10 µg/mL ...
-
bioRxiv - Developmental Biology 2023Quote: ... blocked using 5% donkey serum or 5% BSA in PBST for 1 hour at RT and incubated overnight at 4°C with primary antibodies diluted in the blocking solution: CD31 (R&D systems; AF3628; 1:500), Aggrecan (Millipore ...
-
bioRxiv - Cancer Biology 2023Quote: ... blocking in 10% donkey serum was followed by overnight incubation at 4ºC with anti-CD31 (1:100; R&D Systems) and subsequent incubation with a fluorescent secondary antibody ...
-
bioRxiv - Cell Biology 2022Quote: ... blocked with Mouse on Mouse Blocking Reagent (R&D Systems) 2h and incubated with primary antibody ...
-
bioRxiv - Immunology 2022Quote: ... after blocking with Reagent Diluent (R&D System, ref DY006), 100-μL standard dilutions and samples were added to each well and incubated 2 hours at RT ...
-
bioRxiv - Biochemistry 2020Quote: ... Fluorogenic peptide substrates were obtained from R&D systems, where Mca-YVADAPK(Dnp)-OH (ES007 ...
-
bioRxiv - Neuroscience 2021Quote: ... + β-heregulin peptide (R&D Systems, Cat# 396-HB-050) + forskolin (Cayman Chemical ...
-
bioRxiv - Cell Biology 2019Quote: ... a fluorogenic peptide substrate of MMPs (R&D systems, USA). The fluorgenic substrate (5 μM ...
-
bioRxiv - Neuroscience 2024Quote: ... recombinant control peptide (R&D systems, cat. #4460, Accession # P01863) is mouse melanoma cell line ...
-
bioRxiv - Bioengineering 2023Quote: ... MVN and tumoroid treatments were administered over 4 days through daily media perfusion with an IL8 blocking antibody (20 µg mL-1, #MAB208, R&D Systems), Dexamethasone (5 µM ...